These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32439173)

  • 61. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.
    Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; ; Erhardt S
    Schizophr Res; 2019 Aug; 210():221-227. PubMed ID: 30612841
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 63. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.
    Higuchi T; Matsuo K; Hashida Y; Kitahata K; Ujihara T; Taniguchi A; Yoshie O; Nakayama T; Daibata M
    Cancer Lett; 2019 Jul; 453():184-192. PubMed ID: 30953706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.
    Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP
    J Bone Miner Res; 2015 Mar; 30(3):412-22. PubMed ID: 25264308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CCR4 and its ligands: from bench to bedside.
    Yoshie O; Matsushima K
    Int Immunol; 2015 Jan; 27(1):11-20. PubMed ID: 25087232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
    Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
    Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
    Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
    Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of multiple cytokines and CCR4 in adult T-cell leukemia/lymphoma cells infiltrating the skin.
    Nakayama-Ichiyama S; Yokote T; Hiraoka N; Iwaki K; Takayama A; Kobayashi K; Akioka T; Oka S; Miyoshi T; Takubo T; Tsuji M; Hanafusa T
    J Am Acad Dermatol; 2011 Sep; 65(3):e95-e96. PubMed ID: 21839312
    [No Abstract]   [Full Text] [Related]  

  • 72. CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis.
    Inoue T; Fujishima S; Ikeda E; Yoshie O; Tsukamoto N; Aiso S; Aikawa N; Kubo A; Matsushima K; Yamaguchi K
    Eur Respir J; 2004 Jul; 24(1):49-56. PubMed ID: 15293604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production.
    Li Y; Esain V; Teng L; Xu J; Kwan W; Frost IM; Yzaguirre AD; Cai X; Cortes M; Maijenburg MW; Tober J; Dzierzak E; Orkin SH; Tan K; North TE; Speck NA
    Genes Dev; 2014 Dec; 28(23):2597-612. PubMed ID: 25395663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
    Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
    J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion.
    Qin XJ; Shi HZ; Deng JM; Liang QL; Jiang J; Ye ZJ
    Clin Cancer Res; 2009 Apr; 15(7):2231-7. PubMed ID: 19318474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
    Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
    Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High cord blood levels of the T-helper 2-associated chemokines CCL17 and CCL22 precede allergy development during the first 6 years of life.
    Abelius MS; Ernerudh J; Berg G; Matthiesen L; Nilsson LJ; Jenmalm MC
    Pediatr Res; 2011 Nov; 70(5):495-500. PubMed ID: 21796021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.
    Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R
    Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CCR4 is a determinant of melanoma brain metastasis.
    Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
    Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.
    Hao S; Han X; Wang D; Yang Y; Li Q; Li X; Qiu CH
    Immunology; 2016 Jun; 148(2):174-86. PubMed ID: 26868141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.